Indicator type;Branch of activity;Total
Number of companies carrying out R&D in Biotechnology;Total companies;1,376
Number of companies carrying out R&D in Biotechnology;Agriculture;98
Number of companies carrying out R&D in Biotechnology;Industry and Construction;407
Number of companies carrying out R&D in Biotechnology;Services;871
% Companies by type of biotechnology used: Genetic Code;Total companies;31.4
% Companies by type of biotechnology used: Genetic Code;Agriculture;19.4
% Companies by type of biotechnology used: Genetic Code;Industry and Construction;17.2
% Companies by type of biotechnology used: Genetic Code;Services;39.5
% Companies by type of biotechnology used: Functional Units;Total companies;43.7
% Companies by type of biotechnology used: Functional Units;Agriculture;28.8
% Companies by type of biotechnology used: Functional Units;Industry and Construction;40.3
% Companies by type of biotechnology used: Functional Units;Services;47.0
% Companies by type of biotechnology used: Cell and Tissue Culture and Engineering;Total companies;22.8
% Companies by type of biotechnology used: Cell and Tissue Culture and Engineering;Agriculture;14.6
% Companies by type of biotechnology used: Cell and Tissue Culture and Engineering;Industry and Construction;18.2
% Companies by type of biotechnology used: Cell and Tissue Culture and Engineering;Services;25.9
% Companies by type of biotechnology used: Bioprocesses;Total companies;48.3
% Companies by type of biotechnology used: Bioprocesses;Agriculture;40.3
% Companies by type of biotechnology used: Bioprocesses;Industry and Construction;74.5
% Companies by type of biotechnology used: Bioprocesses;Services;37.0
% Companies by type of biotechnology used: Subcellular Organisms;Total companies;7.9
% Companies by type of biotechnology used: Subcellular Organisms;Agriculture;5.0
% Companies by type of biotechnology used: Subcellular Organisms;Industry and Construction;4.9
% Companies by type of biotechnology used: Subcellular Organisms;Services;9.6
% Companies by type of biotechnology used: Bioinformatics;Total companies;27.1
% Companies by type of biotechnology used: Bioinformatics;Agriculture;11.9
% Companies by type of biotechnology used: Bioinformatics;Industry and Construction;13.0
% Companies by type of biotechnology used: Bioinformatics;Services;35.5
% Companies by type of biotechnology used: Nanobiotechnology;Total companies;11.2
% Companies by type of biotechnology used: Nanobiotechnology;Agriculture;1.1
% Companies by type of biotechnology used: Nanobiotechnology;Industry and Construction;7.2
% Companies by type of biotechnology used: Nanobiotechnology;Services;14.3
% Companies by type of biotechnology used: Other;Total companies;17.6
% Companies by type of biotechnology used: Other;Agriculture;30.3
% Companies by type of biotechnology used: Other;Industry and Construction;9.5
% Companies by type of biotechnology used: Other;Services;20.0
Companies in which biotechnology activities are: Main and/or exclusive;Total companies;711
Companies in which biotechnology activities are: Main and/or exclusive;Agriculture;22
Companies in which biotechnology activities are: Main and/or exclusive;Industry and Construction;112
Companies in which biotechnology activities are: Main and/or exclusive;Services;576
Companies in which biotechnology activities are: A secondary business line;Total companies;270
Companies in which biotechnology activities are: A secondary business line;Agriculture;22
Companies in which biotechnology activities are: A secondary business line;Industry and Construction;107
Companies in which biotechnology activities are: A secondary business line;Services;140
Companies in which biotechnology activities are: A necessary tool for production;Total companies;395
Companies in which biotechnology activities are: A necessary tool for production;Agriculture;53
Companies in which biotechnology activities are: A necessary tool for production;Industry and Construction;188
Companies in which biotechnology activities are: A necessary tool for production;Services;154
% Companies by final application areas of biotechnology use: Human Health;Total companies;48.0
% Companies by final application areas of biotechnology use: Human Health;Agriculture;1.2
% Companies by final application areas of biotechnology use: Human Health;Industry and Construction;25.1
% Companies by final application areas of biotechnology use: Human Health;Services;63.9
% Companies by final application areas of biotechnology use: Animal Health and Aquaculture;Total companies;16.9
% Companies by final application areas of biotechnology use: Animal Health and Aquaculture;Agriculture;27.6
% Companies by final application areas of biotechnology use: Animal Health and Aquaculture;Industry and Construction;14.0
% Companies by final application areas of biotechnology use: Animal Health and Aquaculture;Services;17.0
% Companies by final application areas of biotechnology use: Food Products;Total companies;29.4
% Companies by final application areas of biotechnology use: Food Products;Agriculture;26.9
% Companies by final application areas of biotechnology use: Food Products;Industry and Construction;48.0
% Companies by final application areas of biotechnology use: Food Products;Services;21.0
% Companies by final application areas of biotechnology use: Agriculture and Forestry;Total companies;25.7
% Companies by final application areas of biotechnology use: Agriculture and Forestry;Agriculture;69.5
% Companies by final application areas of biotechnology use: Agriculture and Forestry;Industry and Construction;25.4
% Companies by final application areas of biotechnology use: Agriculture and Forestry;Services;20.9
% Companies by final application areas of biotechnology use: Environment;Total companies;18.0
% Companies by final application areas of biotechnology use: Environment;Agriculture;12.4
% Companies by final application areas of biotechnology use: Environment;Industry and Construction;20.9
% Companies by final application areas of biotechnology use: Environment;Services;17.4
% Companies by final application areas of biotechnology use: Industry;Total companies;13.0
% Companies by final application areas of biotechnology use: Industry;Agriculture;5.5
% Companies by final application areas of biotechnology use: Industry;Industry and Construction;15.5
% Companies by final application areas of biotechnology use: Industry;Services;12.7
R&D personnel in Biotechnology (PP);Total companies;17,257
R&D personnel in Biotechnology (PP);Agriculture;1,029
R&D personnel in Biotechnology (PP);Industry and Construction;4,994
R&D personnel in Biotechnology (PP);Services;11,233
R&D personnel in Biotechnology (PP): Research personnel;Total companies;9,195
R&D personnel in Biotechnology (PP): Research personnel;Agriculture;265
R&D personnel in Biotechnology (PP): Research personnel;Industry and Construction;2,023
R&D personnel in Biotechnology (PP): Research personnel;Services;6,908
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel;Total companies;8,061
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel;Agriculture;764
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel;Industry and Construction;2,972
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel;Services;4,325
R&D personnel in Biotechnology (PP). Women;Total companies;9,980
R&D personnel in Biotechnology (PP). Women;Agriculture;441
R&D personnel in Biotechnology (PP). Women;Industry and Construction;2,831
R&D personnel in Biotechnology (PP). Women;Services;6,709
R&D personnel in Biotechnology (PP). Women: Research personnel;Total companies;5,222
R&D personnel in Biotechnology (PP). Women: Research personnel;Agriculture;109
R&D personnel in Biotechnology (PP). Women: Research personnel;Industry and Construction;1,139
R&D personnel in Biotechnology (PP). Women: Research personnel;Services;3,974
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel;Total companies;4,758
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel;Agriculture;332
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel;Industry and Construction;1,691
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel;Services;2,735
R&D personnel in Biotechnology (FTE);Total companies;12,883.4
R&D personnel in Biotechnology (FTE);Agriculture;700.0
R&D personnel in Biotechnology (FTE);Industry and Construction;3,623.0
R&D personnel in Biotechnology (FTE);Services;8,560.3
R&D personnel in Biotechnology (FTE): Research personnel;Total companies;7,103.2
R&D personnel in Biotechnology (FTE): Research personnel;Agriculture;191.6
R&D personnel in Biotechnology (FTE): Research personnel;Industry and Construction;1,552.1
R&D personnel in Biotechnology (FTE): Research personnel;Services;5,359.5
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel;Total companies;5,780.2
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel;Agriculture;508.5
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel;Industry and Construction;2,070.9
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel;Services;3,200.8
R&D personnel in Biotechnology (FTE). Women;Total companies;7,600.6
R&D personnel in Biotechnology (FTE). Women;Agriculture;304.9
R&D personnel in Biotechnology (FTE). Women;Industry and Construction;2,202.7
R&D personnel in Biotechnology (FTE). Women;Services;5,093.0
R&D personnel in Biotechnology (FTE). Women: Research personnel;Total companies;4,057.0
R&D personnel in Biotechnology (FTE). Women: Research personnel;Agriculture;85.2
R&D personnel in Biotechnology (FTE). Women: Research personnel;Industry and Construction;911.7
R&D personnel in Biotechnology (FTE). Women: Research personnel;Services;3,060.1
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel;Total companies;3,543.7
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel;Agriculture;219.7
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel;Industry and Construction;1,291.0
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel;Services;2,032.9
Expenditure on internal R&D in Biotechnology (thousands of euros);Total companies;1,283,346
Expenditure on internal R&D in Biotechnology (thousands of euros);Agriculture;47,651
Expenditure on internal R&D in Biotechnology (thousands of euros);Industry and Construction;392,948
Expenditure on internal R&D in Biotechnology (thousands of euros);Services;842,746
1) By type of expenditure: Current expenditure;Total companies;1,180,187
1) By type of expenditure: Current expenditure;Agriculture;43,927
1) By type of expenditure: Current expenditure;Industry and Construction;367,183
1) By type of expenditure: Current expenditure;Services;769,077
1.1) Labour expenditure of research personnel;Total companies;372,421
1.1) Labour expenditure of research personnel;Agriculture;9,505
1.1) Labour expenditure of research personnel;Industry and Construction;106,176
1.1) Labour expenditure of research personnel;Services;256,740
1.2) Labour expenditure of technical and auxiliary personnel;Total companies;229,734
1.2) Labour expenditure of technical and auxiliary personnel;Agriculture;18,692
1.2) Labour expenditure of technical and auxiliary personnel;Industry and Construction;87,860
1.2) Labour expenditure of technical and auxiliary personnel;Services;123,182
1.3) Other current expenditure;Total companies;578,032
1.3) Other current expenditure;Agriculture;15,730
1.3) Other current expenditure;Industry and Construction;173,147
1.3) Other current expenditure;Services;389,155
2) By type of expenditure: Capital expenditure;Total companies;103,159
2) By type of expenditure: Capital expenditure;Agriculture;3,725
2) By type of expenditure: Capital expenditure;Industry and Construction;25,766
2) By type of expenditure: Capital expenditure;Services;73,669
2.1) Land and buildings;Total companies;10,889
2.1) Land and buildings;Agriculture;500
2.1) Land and buildings;Industry and Construction;1,158
2.1) Land and buildings;Services;9,231
2.2) Equipment and tools;Total companies;59,204
2.2) Equipment and tools;Agriculture;3,152
2.2) Equipment and tools;Industry and Construction;17,922
2.2) Equipment and tools;Services;38,130
2.3) Acquisition of specific R&D software;Total companies;5,623
2.3) Acquisition of specific R&D software;Agriculture;5
2.3) Acquisition of specific R&D software;Industry and Construction;879
2.3) Acquisition of specific R&D software;Services;4,739
2.4) Other R&D-specific IP products;Total companies;27,442
2.4) Other R&D-specific IP products;Agriculture;67
2.4) Other R&D-specific IP products;Industry and Construction;5,807
2.4) Other R&D-specific IP products;Services;21,569
1.1) By origin of funds: Own funds;Total companies;887,527
1.1) By origin of funds: Own funds;Agriculture;45,510
1.1) By origin of funds: Own funds;Industry and Construction;325,418
1.1) By origin of funds: Own funds;Services;516,599
1.2) By origin of funds: Funds from the Business sector;Total companies;143,903
1.2) By origin of funds: Funds from the Business sector;Agriculture;280
1.2) By origin of funds: Funds from the Business sector;Industry and Construction;3,861
1.2) By origin of funds: Funds from the Business sector;Services;139,762
1.3) By origin of funds: Funds from the Public Administration sector;Total companies;126,546
1.3) By origin of funds: Funds from the Public Administration sector;Agriculture;1,841
1.3) By origin of funds: Funds from the Public Administration sector;Industry and Construction;15,631
1.3) By origin of funds: Funds from the Public Administration sector;Services;109,074
1.4) By origin of funds: Funds from the Higher Education sector;Total companies;94
1.4) By origin of funds: Funds from the Higher Education sector;Agriculture;0
1.4) By origin of funds: Funds from the Higher Education sector;Industry and Construction;0
1.4) By origin of funds: Funds from the Higher Education sector;Services;94
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector;Total companies;12,623
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector;Agriculture;0
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector;Industry and Construction;47
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector;Services;12,576
1.6) By origin of funds: Funds from the rest of the world;Total companies;112,652
1.6) By origin of funds: Funds from the rest of the world;Agriculture;21
1.6) By origin of funds: Funds from the rest of the world;Industry and Construction;47,991
1.6) By origin of funds: Funds from the rest of the world;Services;64,641
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros);Total companies;137,432
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros);Agriculture;703
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros);Industry and Construction;68,573
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros);Services;68,156
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain;Total companies;88,127
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain;Agriculture;631
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain;Industry and Construction;59,264
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain;Services;28,231
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world;Total companies;49,305
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world;Agriculture;72
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world;Industry and Construction;9,309
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world;Services;39,924
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to capital;Total companies;43.7
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to capital;Agriculture;36.5
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to capital;Industry and Construction;31.4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to capital;Services;50.3
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information;Total companies;16.2
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information;Agriculture;18.8
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information;Industry and Construction;17.3
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information;Services;15.4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to human resources;Total companies;23.7
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to human resources;Agriculture;27.2
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to human resources;Industry and Construction;24.4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Access to human resources;Services;22.9
% Companies that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain;Total companies;14.5
% Companies that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain;Agriculture;13.2
% Companies that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain;Industry and Construction;13.3
% Companies that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain;Services;15.1
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets;Total companies;18.1
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets;Agriculture;13.4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets;Industry and Construction;9.7
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets;Services;22.5
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels;Total companies;19.6
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels;Agriculture;14.1
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels;Industry and Construction;12.5
% Companies that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels;Services;23.5
% Companies that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception;Total companies;19.1
% Companies that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception;Agriculture;19.4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception;Industry and Construction;18.8
% Companies that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception;Services;19.3
% Companies that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements;Total companies;49.8
% Companies that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements;Agriculture;45.6
% Companies that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements;Industry and Construction;46.2
% Companies that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements;Services;52.0
% Companies that consider the following obstacles to the development of biotechnologies as very important: Time/cost;Total companies;59.4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Time/cost;Agriculture;49.4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Time/cost;Industry and Construction;53.4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Time/cost;Services;63.3
% Companies that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting;Total companies;22.3
% Companies that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting;Agriculture;19.4
% Companies that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting;Industry and Construction;18.9
% Companies that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting;Services;24.2
% Companies with international revenues related to biotechnology activities;Total companies;23.6
% Companies with international revenues related to biotechnology activities;Agriculture;8.7
% Companies with international revenues related to biotechnology activities;Industry and Construction;21.1
% Companies with international revenues related to biotechnology activities;Services;26.4
% Companies representing international revenues related to biotechnology activities;Total companies;1.5
% Companies representing international revenues related to biotechnology activities;Agriculture;0.5
% Companies representing international revenues related to biotechnology activities;Industry and Construction;1.3
% Companies representing international revenues related to biotechnology activities;Services;2.7
% International revenues related to biotechnology activities distributed in: Revenues from the EU;Total companies;57.6
% International revenues related to biotechnology activities distributed in: Revenues from the EU;Agriculture;58.1
% International revenues related to biotechnology activities distributed in: Revenues from the EU;Industry and Construction;58.3
% International revenues related to biotechnology activities distributed in: Revenues from the EU;Services;54.9
% International revenues related to biotechnology activities distributed in: Revenues from the rest of the world;Total companies;42.4
% International revenues related to biotechnology activities distributed in: Revenues from the rest of the world;Agriculture;41.9
% International revenues related to biotechnology activities distributed in: Revenues from the rest of the world;Industry and Construction;41.7
% International revenues related to biotechnology activities distributed in: Revenues from the rest of the world;Services;45.1
% International revenues related to biotechnology activities by classification: International trade in goods and services;Total companies;82.3
% International revenues related to biotechnology activities by classification: International trade in goods and services;Agriculture;64.5
% International revenues related to biotechnology activities by classification: International trade in goods and services;Industry and Construction;83.1
% International revenues related to biotechnology activities by classification: International trade in goods and services;Services;79.9
% International revenues related to biotechnology activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Total companies;14.1
% International revenues related to biotechnology activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Agriculture;35.0
% International revenues related to biotechnology activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Industry and Construction;15.6
% International revenues related to biotechnology activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Services;7.9
% International revenues related to biotechnology activities by classification: Subsidies from external sources;Total companies;1.5
% International revenues related to biotechnology activities by classification: Subsidies from external sources;Agriculture;0.0
% International revenues related to biotechnology activities by classification: Subsidies from external sources;Industry and Construction;0.0
% International revenues related to biotechnology activities by classification: Subsidies from external sources;Services;7.0
% International revenues related to biotechnology activities by classification: Other;Total companies;2.1
% International revenues related to biotechnology activities by classification: Other;Agriculture;0.5
% International revenues related to biotechnology activities by classification: Other;Industry and Construction;1.2
% International revenues related to biotechnology activities by classification: Other;Services;5.2